PANTHER
LIVE

Serial Number

99434165

Owner

PanTher Therapeutics, Inc.

Attorney

Jessica L. Rothstein

First Use Date

Jun 19, 2017

Filing Date

Oct 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PANTHER Trademark

Serial Number: 99434165

PANTHER is a trademark filed by PanTher Therapeutics, Inc. on October 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

PanTher Therapeutics, Inc.

7000 BEE CAVES ROAD, SUITE 300
AUSTIN, TX 78746

Entity Type: 03

Trademark Details

Filing Date

October 9, 2025

Registration Date

Not Registered

First Use Anywhere

June 19, 2017

First Use in Commerce

June 19, 2017

Goods & Services

Pharmaceutical products in the nature of implantable solid drug formulations for the treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate delivery of pharmaceuticals for the prevention, diagnosis, and treatment of cancer; Pharmaceutical products and drug delivery platforms in the nature of compounds that facilitate localized delivery of pharmaceuticals for the sustained treatment of cancer; Pharmaceutical products in the nature of implantable solid drug formulations that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer

Implantable solid drug formulations to treat cancer; Drug delivery system in the nature of a system that delivers an implantable solid drug formulation to treat cancer; Drug delivery system in the nature of a system to prevent, diagnose, and treat cancer; Drug delivery system that facilitates delivery of pharmaceuticals that improve therapeutic efficacy, minimize systemic toxicity, and expand treatment options, all related to cancer

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 14, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 14, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2026 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2026 REAP
ASSIGNED TO EXAMINER
Feb 26, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 9, 2025 MAFR
NEW APPLICATION ENTERED
Oct 9, 2025 NWAP